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Miocardiopatia terminal com insuficiência mitral secundária: tratamento com implante de prótese e
remodelamento interno do ventrículo esquerdo
End stage cardiomyopathy and secondary mitral
insufficiency: surgical alternative with prostesis
implant and left ventricular remodeling
Abstract
Objective: To present a new surgical approach that consists
of the implantation of a mitral prosthesis smaller than the
annulus with traction of the papillary muscles to reduce the
sphericity of the left ventricle.
Method: Between December 1995 and September 2005,
116 heart disease patients were operated, all of whom were at
end-stage despite of full medication. The patients were
analysed according to clinical criteria, echocardiographic
findings and morphology of the left ventricle.
Results: Hospital mortality was 16.3% (19/116) and mid-
term follow-up (38 ± 16 months) showed evidence of
improvement in the clinical status and some
echocardiographic parameters, in particular reduction of the
sphericity of the left ventricle.
Conclusion: This technique, despite of the high mortality
rate, offers a promising therapeutic alternative for the
treatment of patients in refractory heart failure with
cardiomyopathy associated to moderate or severe secondary
mitral regurgitation.
Descriptors: Congestive heart failure. Dilated
cardiomyopathy. Mitral valve insufficiency.
Resumo
Objetivo: Analisar o resultado de uma alternativa
operatória que envolve a correção da regurgitação mitral pelo
implante de uma prótese de diâmetro menor do que o anel
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INTRODUCTION
Currently, there are high incidences and prevalences of
Congestive Heart Failure (CHF) with approximately 23
millions of people suffering from this disease and 2 millions
of new cases diagnosed each year worldwide [1,2].
The gold standard for these patients is heart
transplantation, but due to the low number of donors and
the rigorous criteria of indication, a large number of these
patients die whilst waiting for the definitive treatment [3-5].
The long-term result in this group of patients is not
satisfactory due to high rates of mortality. Thus, in an attempt
to benefit a greater number of patients, a series of alternative
surgical procedures have been proposed including
cardiomyopathy, partial left ventriculectomy, surgical
correction of mitral valve regurgitation, biventricular heart
pacing and myocardial revascularization either as an isolated
procedure or associated to ventricular repair [6-11].
Mitral valve regurgitation in patients with dilated
cardiomyopathy is linked to a reduction in short-term
survival rates [12]. Mitral valve regurgitation is associated
to the interaction of several factors: segmental changes in
ventricular contractility, papillary muscle dysfunction,
dilatation of the mitral valvar annulus and in particular,
geometrical changes of the ventricular cavity with loss of
its elliptical form [13].
By analyzing patients who had been submitted to partial
left ventriculectomy and publications on the subject, a
functional improvement was identified mainly in patients
with surgical correction of mitral valve regurgitation. Based
on these data a surgical technique was proposed that
involves the surgical correction of mitral valve regurgitation
with the implantation of a prosthesis smaller than the valvar
annulus associated with internal remodeling of the left
ventricular cavity by shortening the longitudinal axis.
The goal of this work is to analyze the impact of this
surgical technique on patients with advanced dilated
cardiomyopathy and secondary mitral valve regurgitation,
by means of clinical and echocardiographic data.
METHOD
Between December 1995 and September 2005, 116
patients with advanced dilated cardiomyopathy and
moderate to severe mitral valve regurgitation were submitted
to the surgical procedure discussed in this work. The group
constituted of 65 (55.10%) male patients and ages ranged
from 25 to 82 years (mean of 62 ± 12 years); 23 (19.50%)
patients were over 70 years old.
In regards to the etiology of the cardiomyopathy, in 68
cases (58.60%) it was ischemic, 43 (37.10%) idiopathic, three
(2.58%) chagasic, one (0.86%) viral and one (0.86%)
gestational.
All the patients had been hospitalized at least twice
within the previous three months for congestion in spite of
adequate medication. According to the classification of the
New York Heart Association (NYHA) 83% were in functional
class (FC) IV and 17% in FC III in the immediate preoperative
period. Eleven patients were in the intensive care unit on
circulatory support taking vasoactive drugs and using an
intra-aortic balloon pump; two patients were in dialytic
program and one was in cardiogenic chock. Moreover, 21
patients had previously been submitted to heart surgery for
coronary artery bypass grafting (CABG), left ventricular
aneurysmectomy, partial left ventriculectomy and/or
ventricular resynchronization, either in isolation or
associated. The mean follow-up time after surgery was from
38 ± 16 months.
Inclusion criteria were: advanced CHF (with two or more
periods in hospital within the previous three months due to
the congestion) and moderate or severe mitral valve
regurgitation as diagnosed by transesophageal
echocardiogram. The exclusion criteria were organic
diseases of the mitral valve, associated aortic valvuloplasty
mitral e redução da esfericidade do ventrículo esquerdo com
tração dos músculos papilares em direção ao anel, em
portadores de miocardiopatia terminal e regurgitação mitral
secundária.
Método: Entre dezembro de 1995 e setembro de 2005, 116
pacientes foram operados com a técnica proposta. Os pacientes
foram analisados de acordo com critérios clínicos, dados
ecocardiográficos e aspectos morfológicos do ventrículo
esquerdo.
Resultado: A mortalidade hospitalar foi 16,3% (19/116). O
tempo médio de acompanhamento foi 38±16 meses. Após a
alta hospitalar, a curva atuarial de sobrevida permaneceu
estável com aceitável taxa de mortalidade tardia. Observou-
se importante melhora clínica dos pacientes e de alguns
parâmetros ecocardiográficos, especialmente redução da
esfericidade do ventrículo esquerdo.
Conclusões: Apesar da alta mortalidade operatória, a
técnica apresentada representa uma alternativa aceitável no
tratamento de portadores de miocardiopatia terminal com
insuficiência cardíaca refratária associada à regurgitação
mitral secundária.
Descritores: Insuficiência cardíaca congestiva.
Cardiomiopatia dilatada. Insuficiência da valva mitral.
285
and ischemic disease with indication for CABG (with
confirmed myocardial viability) and/or ventricular repair.
The study protocol was approved by the Ethics and
Research Commission of the Paulista School of Medicine
and the patients agreed to participate in the study by signing
an informed consent form.
Surgical technique
The surgery was initiated with hemodynamical
monitoring including measurement of the mean arterial
pressure, central venous pressure and urinary excretion, as
well as respiratory monitoring by pulse oximetry.
The surgery followed the normal manner; medium
sternotomy was performed with cannulation of the aorta
and the superior and inferior vena cavae through the right
atrium after systemic heparinization (4 mg/kg) under
moderate hypothermia of 32ºC.
Hypothermic anterograde sanguineous cardioplegia (at
approximately 18ºC) was utilized as myocardial protection
with added potassium (15mEq/L) during induction. For
subsequent doses, at 15-minute intervals, blood at 32ºC was
added to the perfusate without the addition of any other
substances.
The mitral valve was approached by means of
longitudinal left or transseptal atriotomy depending on the
diameter of left atrium. The anterior leaflet was sectioned in
half, according to the technique described by Miki et al.
[14], creating two halves whose angles were sutured to the
commissures. The aim of this was to shorten the longitudinal
axis of the heart using the traction of the papillary muscles
and consequently to restore the elliptical form of the left
ventricle.
After this a prosthesis, smaller than the mitral valvar
annulus, was implanted with preservation of the posterior
leaflet. Of the total prostheses utilized, 111 were biological
and five were mechanical, with diameters as follows: 25 (two
cases), 27 (48), 29 (43), 31 (20) and 33 (three).
For patients with an ischemic etiology, 64.70% (44/68)
were submitted to associated procedures: CABG (19),
exclusion of fibrotic areas (20) or both (three) and ventricular
resynchronization (two).
At the end of the surgery, the patients in normothermia
were transferred to the recovery unit where they were
continuously monitored.
All the patients were accompanied during the hospital
and out-patient evolution by the same member of the surgical
team, with the protocol completed to compare pre- and
postoperative data.
Statistical analysis
Statistical analysis consisted in a comparison of
parameters studied in the three observational periods of
observation, when data were collected for all patients. The
observations were recorded in the following periods:
1.Before surgery – immediate preoperative observation;
2. Before hospital discharge – postoperative observation;
3. After hospital discharge – last assessment.
The parameters evaluated were:
• Left ventricular ejection fraction (LVEF);
• Left ventricular ejection volume (LVEV);
• Ratio between the long and short axes of the left
ventricle.
Friedman’s test was utilized to analyze the results by
comparing pre- and postoperative values. Statistical
significance was established at a p-value = 0.05. Analysis of
survival was obtained using the Kaplan-Meier’s curve.
RESULTS
The hospital mortality rate was 16.30% (19/116) with the
main causes of death being low cardiac output syndrome
(seven), multiple organ failure (four), strokes (two),
bronchopneumonia (three), refractory arrhythmia (one),
sudden death (one) and mesenteric thrombosis (one).
Of the 116 patients included in this study, 97 were
discharged from hospital and were accompanied in the
outpatient clinic for a follow-up period of from 1 to 118 months
(mean of 38 ± 16 months).
After hospital discharge, the actuarial survival curve
remained stable with an acceptable long-term mortality rate
(Figure 1).
There was a significant improvement in the functional
class, where in the preoperative period 83% of patients
had been in FC IV and 17% in FC III (at the time of surgery),
in the last postoperative assessment (performed in all
patients that were discharged from hospital) 77% were in
FC II and 15% in FC I. Eight per cent of patients remained
in FC IV, among whom two are on the transplantation list
and another two have already been submitted to this
procedure (Figure 2).
Fig. 1 – actuarial survival curve
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Fig. 3 – Ejection fraction in the preoperative period, before hospital
discharge and six months after surgery
Fig. 4 – Ejection volume in the preoperative period, before hospital
discharge and six months after the surgery
Fig. 5 - Left ventricular sphericity index – Reduction of the left
ventricular sphericity calculated as a ratio between the long and
short axes using nuclear magnetic resonance
Fig. 2 – Pre- and Postoperative Functional Class, with 83% of
patients in functional class III in the preoperative period and 77%
in functional class II over a mean follow-up period of 6 months
The left ventricular ejection fraction and the ejection
volume were analyzed by transesophageal echocardiogram,
with data obtained in the postoperative period (before
hospital discharge) and during assessments as out-patients.
There was a modest but significant increase in the ejection
fraction between both observation periods. Additionally,
there was a significant increase in the ejection volume seen
between the observation periods (Figures 3 and 4).
There was a reduction of left ventricular sphericity that
was analysed by measuring the sphericity index, which
corresponds to the ratio between the two axes of the left
ventricle (width and height), obtained by nuclear magnetic
resonance imaging performed for 12 consecutive patients
(Figure 5).
DISCUSSION
The clinical treatment of CHF is based on knowledge of
the hemodynamical and neuro-humoral mechanisms of this
syndrome, but these therapeutic modalities are not
definitive; they offer only a temporary improvement in the
quality of life [15]. Despite optimization of the clinical
treatment, a considerable percentage of these patients
evolve to more advanced stages of the disease and heart
transplantation is the treatment of choice.
Patients with CHF may be basically cared for by medicinal
treatment (this delays the evolution of the disease, but does
not cure it) and with elective surgical treatment, that is, heart
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transplantation (which is not possible for all patients).
Thus, alternative forms of surgical treatment are used in
an attempt to increase the survival of these patients,
sometimes maintaining them alive until definitive surgical
treatment.
Evolution to functional mitral valve regurgitation in patients
with dilated cardiomyopathy is associated with deterioration
of the hemodynamical state and reduces the survival rate [16].
The presence of mitral valve regurgitation causes volumetric
and pressure overloads with dilation of the left ventricular
cavity. The increase in the parietal tension favors distension of
the myofibrils, reduction of the contractile capacity and
increases in the myocardial oxygen consumption.
Bolling et al. [17,18] proposed reducing mitral valve leaks
by performing valvuloplasty but respecting the integrity of
the mitral valve system. In a 12-month clinical follow-up the
authors observed reductions in the mortality rate, the
quantity of medicine required to treat CHF and the
congestive symptoms.
Calafiore et al. [19] on comparing several surgical
techniques used in the treatment of end-stage dilated
cardiomyopathy showed that treatment of the mitral valve
causes lower rates of intra-hospital mortality and deaths
over the medium-term clinical follow-up.
Understanding the importance of eliminating mitral valve
regurgitation in patients with dilated cardiomyopathy,
Buffolo et al. [9] and Paula [16] proposed a technique that
associates prosthesis implantation in the mitral valve
position with the repair of the anterior leaflet, aiming at re-
establishing the normal position of the papillary muscles in
the mitral valvar annulus. In this technique, ventricular
restoration occurs due to the shortening of the largest
ventricular axis after realignment of the papillary muscles
and by the implantation of a smaller prosthesis than the
valvar annulus [20].
In this work, we presented the results of the
aforementioned technique indicated for advanced dilated
cardiomyopathy patients with moderate or severe functional
mitral valve regurgitation. Initially, the proposal of a new
operative alternative for treatment of refractory CHF was
based on observations of the results obtained in patients
submitted to left partial ventriculectomy, in which there was
a more evident functional improvement when some type of
intervention of the mitral valve was performed.
The appearance of functional mitral valve regurgitation
is related to anatomical alterations involving the mitral valvar
and subvalvar apparatuses, as well as the left ventricle
cavity. Thus, increases of the mitral valve annulus and
consequently of the heart base are associated to a loss of
the alignment of papillary muscle due to left ventricle dilation
and a greater degree of mitral valve regurgitation [21].
The proposed technique involves the repair of all these
anatomic alterations, that is, correction of the mitral valve
regurgitation, restoration of the shape of the left ventricle,
realignment of the papillary muscles and reduction of the
sphericity index of the left ventricle and, finally, reduction
and “bandaging” of the base of the heart by implanting a
prosthesis smaller than the mitral annulus.
In this series, despite of the high operative mortality, in
many cases related to specific high-risk clinical conditions
at the time of the surgery, the actuarial survival curve was
stable after hospital discharge, with a low late mortality rate.
The follow-up of these patients revealed a significant
improvement in the functional class; 92% of them presented
an improvement compared to before the surgery (Figure 2),
with probable benefits to their quality of life.
In respect to echocardiographic parameters, it seems that
the LVEF is not the most accurate parameter to determine
long-term results but an analysis of the ventricular volume
is essential [22,23]. Even so, a modest but significant increase
in the LVEF was observed between the pre- and
postoperative periods (Figure 3). After eliminating
regurgitation to the left atrium, a significant increase in the
left ventricular ejection volume was observed between the
pre- and postoperative periods.
The size of the left ventricle after restoration of the
geometrical shape is a factor related to the survival of these
patients and in this study, we analyzed the ventricular
sphericity index, which corresponds to the ratio between
the long and short axes measured by nuclear magnetic
resonance. The data obtained from 12 consecutive patients
showed a reduction of this index and so there was a
reduction in the ventricular sphericity.
Thus, despite of the severity of the clinical situation,
this technique offers an alternative surgical treatment for
CHF that may reduce congestive symptoms and possibly
provide an increase in life expectancy. This principally results
in a better quality of life however, further prospective studies
are necessary to assess the results obtained in this study
over the long term.
CONCLUSION
1. An improvement in the functional class was observed
in 92% of the patients studied when comparing the pre- and
postoperative data.
2.There was a modest, but statistically significant,
increase in the left ventricular ejection fraction comparing
the pre- and postoperative data.
3. There was a significant increase of the left ventricular
ejection volume comparing the pre- and postoperative
values.
4. There was a reduction in the left ventricular sphericity
index, assessed by nuclear magnetic resonance.
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